In Brief This Week: Bio-Rad Laboratories; Exact Sciences; Thermo Fisher; BD; Sigma-Aldrich; Diagenode; Promega; SAP, MolecularHealth; Gen9 | GenomeWeb

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories said in a filing with the US Securities and Exchange Commission this week that the total consideration for its acquisition of Propel Labs' cell sorting system was $49.6 million. The firm announced the acquisition a couple of weeks ago but had said at the time that the purchase price was undisclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.